Cargando…

Inhibiting CBP Decreases AR Expression and Inhibits Proliferation in Benign Prostate Epithelial Cells

(1) Background: CREB-binding protein (CBP) is a key transcriptional coactivator of androgen receptors (AR). We conducted this study to investigate the effects of CBP on AR expression and proliferation in benign prostatic hyperplasia (BPH) prostate epithelial cells. (2) Methods: By analyzing a publis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Xingxing, Liu, Zhifu, Li, Zheng, Huang, Chenchen, Yu, Wei, Fan, Yu, Hu, Shuai, Jin, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669082/ https://www.ncbi.nlm.nih.gov/pubmed/38002029 http://dx.doi.org/10.3390/biomedicines11113028

Ejemplares similares

Metformin inhibits the proliferation of benign prostatic epithelial cells
por: Wang, Zongwei, et al.
Publicado: (2017)

Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation
por: Zhang, Bo, et al.
Publicado: (2021)

Stromal AR inhibits prostate tumor progression by restraining secretory luminal epithelial cells
por: Liu, Yueli, et al.
Publicado: (2022)

Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells
por: Jung, Yunu, et al.
Publicado: (2017)

Smoothened inhibition leads to decreased cell proliferation and suppressed tissue fibrosis in the development of benign prostatic hyperplasia
por: Liu, Jianmin, et al.
Publicado: (2021)

SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer
por: Ding, Mao, et al.
Publicado: (2020)

Correction: Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells
por: Jung, Yunu, et al.
Publicado: (2019)

Huaier Extract Inhibits Prostate Cancer Growth via Targeting AR/AR-V7 Pathway
por: Liu, Zhengfang, et al.
Publicado: (2021)

Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells
por: Han, Yangyang, et al.
Publicado: (2017)

GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition
por: Kim, Yejin, et al.
Publicado: (2021)

Inhibition of CREB-CBP Signaling Improves Fibroblast Plasticity for Direct Cardiac Reprogramming
por: Bektik, Emre, et al.
Publicado: (2021)

Cyclopamine functions as a suppressor of benign prostatic hyperplasia by inhibiting epithelial and stromal cell proliferation via suppression of the Hedgehog signaling pathway
por: Yuan, Yi-Feng, et al.
Publicado: (2020)

Inhibition of β‐catenin/CBP signalling improves airway epithelial barrier function and suppresses CCL20 release
por: Kuchibhotla, Virinchi N. S., et al.
Publicado: (2020)

Down-Regulation of C3aR/C5aR Inhibits Cell Proliferation and EMT in Hepatocellular Carcinoma
por: Chen, Bendong, et al.
Publicado: (2020)

USP12 translocation maintains interferon antiviral efficacy by inhibiting CBP acetyltransferase activity
por: Liu, Jin, et al.
Publicado: (2020)

Ar-turmerone inhibits the proliferation and mobility of glioma by downregulating cathepsin B
por: Cao, Wenpeng, et al.
Publicado: (2023)

p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer
por: Liu, Jinghui, et al.
Publicado: (2020)

Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction
por: Xu, Defeng, et al.
Publicado: (2017)

HBZ inhibits the HAT activity of the cellular coactivators p300 and CBP
por: Wright, Diana, et al.
Publicado: (2011)

P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy
por: Jia, Yu-Li, et al.
Publicado: (2016)

Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment
por: Makino, Tomoyuki, et al.
Publicado: (2021)

Regulation of AR mRNA translation in response to acute AR pathway inhibition
por: Somasekharan, Syam Prakash, et al.
Publicado: (2021)

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression
por: Stuchbery, Ryan, et al.
Publicado: (2016)

Antioxidant mitoquinone suppresses benign prostatic hyperplasia by regulating the AR–NLRP3 pathway
por: Jin, Bo-Ram, et al.
Publicado: (2023)

CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway
por: Yang, Yang, et al.
Publicado: (2017)

Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity
por: Shirakawa, Kotaro, et al.
Publicado: (2016)

Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis
por: Diesch, Jeannine, et al.
Publicado: (2021)

Domain-Independent Inhibition of CBP/p300 Attenuates α-Synuclein Aggregation
por: Hlushchuk, Irena, et al.
Publicado: (2021)

Inhibition of CBP/β‐catenin signaling ameliorated fibrosis in cholestatic liver disease
por: Kimura, Masamichi, et al.
Publicado: (2022)

Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC)
por: Chandrasekaran, Balaji, et al.
Publicado: (2023)

Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer
por: Zhang, Li, et al.
Publicado: (2016)

Stilbene Induced Inhibition of Androgen Receptor Dimerization: Implications for AR and ARΔLBD-Signalling in Human Prostate Cancer Cells
por: Streicher, Wolfgang, et al.
Publicado: (2014)

CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells
por: Ito, Saya, et al.
Publicado: (2018)

Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta.
por: Kooistra, A., et al.
Publicado: (1995)

Increased Notch signaling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells
por: Kwon, Oh-Joon, et al.
Publicado: (2014)

p300/CBP-associated factor promotes autophagic degradation of δ-catenin through acetylation and decreases prostate cancer tumorigenicity
por: Zhou, Rui, et al.
Publicado: (2019)

Liquiritigenin Inhibits Colorectal Cancer Proliferation, Invasion, and Epithelial-to-Mesenchymal Transition by Decreasing Expression of Runt-Related Transcription Factor 2
por: Meng, Fan-Chun, et al.
Publicado: (2019)

Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells
por: Kim, Young-Chae, et al.
Publicado: (2015)

Temsirolimus Inhibits Proliferation and Migration in Retinal Pigment Epithelial and Endothelial Cells via mTOR Inhibition and Decreases VEGF and PDGF Expression
por: Liegl, Raffael, et al.
Publicado: (2014)

Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR
por: Schayowitz, A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_hvr6l4ht1q7745d51ipmndhqsd